首页> 外文期刊>BMC Nephrology >Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis
【24h】

Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

机译:对比相关的急性肾脏损伤预防方法的有效性;系统评价和网络荟萃分析

获取原文
           

摘要

Different methods to prevent contrast-associated acute kidney injury (CA-AKI) have been proposed in recent years. We performed a mixed treatment comparison to evaluate and rank suggested interventions. A comprehensive Systematic review and a Bayesian network meta-analysis of randomised controlled trials was completed. Results were tabulated and graphically represented using a network diagram; forest plots and league tables were shown to rank treatments by the surface under the cumulative ranking curve (SUCRA). A stacked bar chart rankogram was generated. We performed main analysis with 200 RCTs and three analyses according to contrast media and high or normal baseline renal profile that includes 173, 112 & 60 RCTs respectively. We have included 200 trials with 42,273 patients and 44 interventions. The primary outcome was CI-AKI, defined as ≥25% relative increase or?≥?0.5?mg/dl increase from baseline creatinine one to 5 days post contrast exposure. The top ranked interventions through different analyses were Allopurinol, Prostaglandin E1 (PGE1) & Oxygen (0.9647, 0.7809 & 0.7527 in the main analysis). Comparatively, reference treatment intravenous hydration was ranked lower but better than Placebo (0.3124 VS 0.2694 in the main analysis). Multiple CA-AKI preventive interventions have been tested in RCTs. This network evaluates data for all the explored options. The results suggest that some options (particularly allopurinol, PGE1 & Oxygen) deserve further evaluation in a larger well-designed RCTs.
机译:近年来,已提出了多种预防对比剂相关的急性肾损伤(CA-AKI)的方法。我们进行了混合治疗比较,以评估建议的干预措施并对其进行排名。随机对照试验的全面系统评价和贝叶斯网络荟萃分析已完成。将结果制成表格并使用网络图以图形方式表示;示出了森林地块和等级表通过累积排名曲线(SUCRA)下的表面对处理进行排名。生成了堆叠的条形图高度图。我们根据200项RCT进行了主要分析,并根据造影剂和基线水平较高或正常的肾脏进行了三项分析,分别包括173、112和60个RCT。我们纳入了200项试验,涉及42273例患者和44项干预措施。主要结果为CI-AKI,定义为对比暴露后1至5天相对于基线肌酐增加≥25%或≥≥0.5µmg / dl。通过不同分析得出的排名最高的干预措施是别嘌醇,前列腺素E1(PGE1)和氧气(主要分析为0.9647、0.7809和0.7527)。比较而言,参考治疗的静脉水合作用排名较低,但优于安慰剂(主要分析为0.3124 VS 0.2694)。在RCT中已经测试了多种CA-AKI预防性干预措施。该网络评估所有探索选项的数据。结果表明,某些选项(尤其是别嘌醇,PGE1和氧气)在较大设计良好的RCT中值得进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号